Apr 12, 2021 / 12:00PM GMT
Operator
Good morning. Welcome to Sage Therapeutics conference call to discuss the results of the KINETIC study. (Operator Instructions)
This call is being webcast live on the Investors and Media section of Sage's website at sagerx.com. This call is property of Sage Therapeutics, and recordings, reproduction and transmission of this call without expressed written consent of Sage Therapeutics is strictly prohibited. Please note, this call is being recorded.
I would now like to introduce Jeff Boyle, Vice President, Investor Relations at Sage.
Jeff Boyle - Sage Therapeutics, Inc. - Investor Contact
Good morning, and thank you for joining Sage Therapeutics conference call to discuss results from the KINETIC study with SAGE-324 in essential tremor. Before I begin, I encourage everyone to go to the Investors and Media section of our website at sagerx.com, where you can find the press release related to today's call.
I'd like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs.
SAGE Therapeutics Inc KINETIC Study Topline Results Conference Call Transcript
Apr 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers